Publications of S. Lucae

Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S.; Ripke, S. et al.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Polymorphisms in the Angiotensin-Converting Enzyme Gene Region Predict Coping Styles in Healthy Adults and Depressed Patients. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 150B (1), pp. 104 - 114 (2009)

Hennings, J. M.; Owashi, T.; Binder, E. B.; Horstmann, S.; Menke, A.; Kloiber, S.; Dose, T.; Wollweber, B.; Spieler, D.; Messer, T. et al.; Lutz, R.; Künzel, H.; Bierner, T.; Pollmächer, T.; Pfister, H.; Nickel, T.; Sonntag, A.; Uhr, M.; Ising, M.; Holsboer, F.; Lucae, S.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 43 (3), pp. 215 - 229 (2009)

Hennings, J.; Owashi, T.; Binder, E.; Horstmann, S.; Menke, A.; Kloiber, S.; Dose, T.; Wollweber, B.; Spieler, D.; Messer, T. et al.; Künzel, H.; Bierner, T.; Pollmächer, T.; Pfister, H.; Nickel, T.; Sonntag, A.; Uhr, M.; Ising, M.; Holsboer, F.; Lucae, S.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich antidepressant response signature project. International Journal of Psychiatry in Clinical Practice 13 (Suppl. 1), pp. 31 - 32 (2009)

Heck, A.; Lieb, R.; Unschuld, P.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S. et al.; Ripke, S.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Molecular Psychiatry 13 (9), pp. 831 - 832 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Ising, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E.: Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients. European Neuropsychopharmacology 18 (Suppl. 4), pp. S214 - S215 (2008)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ising, M.; Uhr, M.; Menke, A.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 18 (Suppl. 4), p. S296 - S296 (2008)

Reppermund, S.; Lieb, R.; Heck, A.; Ellgas, A.; Lucae, S.; Holsboer, F.; Ising, M.: The role of the dopamine beta-hydroxylase (DBH) gene in human cognitive function. European Neuropsychopharmacology 18 (Suppl. 4), p. S281 - S281 (2008)

Hennings, J.; Owashi, T.; Ising, M.; Holsboer, F.; Lucae, S.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings front the Munich antidepressant response signature (MARS) project. International Journal of Neuropsychopharmacology 11 (Suppl. 1), p. 204 - 204 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Kohli, M.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Association of GRIK4 and 5-HTR2A with antidepressant treatment in the MARS cohort of depressed impatients. International Journal of Neuropsychopharmacology 11 (Suppl. 1), pp. 112 - 113 (2008)

Ising, M.; Silja, A.; Lucae, S.; Siebertz, A.; Depping, A. M.; Modell, S.; Müller-Myhsok, B.; Holsboer, F.: Molecular genetics of individual differences: What can we learn for related disorders? International Journal of Psychology 43 (3-4), p. 195 - 195 (2008)

Menke, A.; Lucae, S.; Kloiber, S.; Horstmann, S.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Polymorphisms in metabotropic glutamate receptor 1 are associated with major depressive disorder. Biological Psychiatry 63 (7 Suppl. S), pp. 83S - 84S (2008)

Erhardt, A.; Lucae, S.; Kern, N.; Unschuld, P. G.; Ising, M.; Lieb, R.; Uhr, M.; Hohoff, C.; Deckert, J.; Bandelow, B. et al.; Maier, W.; Binder, E. B.; Müller-Myhsok, B.; Keck, M. E.; Holsboer, F.: Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Molecular Psychiatry 13 (3), pp. 242 - 243 (2008)

Menke, A.; Lucae, S.; Kloiber, S.; Horstmann, S.; Uhr, M.; Pütz, B.; Ripke, S.; Müller-Myhsok, B.: Glutamate and interleukin receptor genes are associated with antidepressant treatment emergent suicidal ideation. European Neuropsychopharmacology 18 (Suppl. 1), pp. S70 - S71 (2008)

Ising, M.; Depping, A.-M.; Siebertz, A.; Lucae, S.; Unschuld, P. G.; Kloiber, S.; Horstmann, S.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the FKBP5 gene region modulates recovery from psychosocial stress in healthy controls. European Journal of Neuroscience 28, pp. 389 - 398 (2008)

Uhr, M.; Tontsch, A.; Namendorf, C.; Ripke, S.; Lucae, S.; Ising, M.; Dose, T.; Ebinger, M.; Rosenhagen, M.; Kohli, M. et al.; Kloiber, S.; Salyakina, D.; Bettecken, T.; Specht, M.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, pp. 203 - 209 (2008)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kohli, M.; Kloiber, S.; Salyakina, D.; Thoeringer, C. K.; Kern, N.; Lieb, R. et al.; Uhr, M.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of Affective Disorders 105, pp. 177 - 184 (2008)

Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S.; Ripke, S. et al.; Mueller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients. Pharmacopsychiatry 40 (5), p. 209 - 209 (2007)

Kloiber, S.; Ripke, S.; Kohli, M.; Reppermund, S.; Salyakina, D.; Bettecken, T.; Ising, M.; Uhr, M.; Horstmann, S.; Dose, T. et al.; Unschuld, P. G.; Zihl, J.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Polymorphisms in the leptin gene are associated with resistance to antidepressant treatment and lower cognitive performance in depression. Pharmacopsychiatry 40 (5), pp. 210 - 211 (2007)

Kohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Lieb, R. et al.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)

Kohli, M. A.; Salyakina, D.; Lucae, S.; Ising, M.; Bettecken, T.; Ripke, S.; Uhr, M.; Kloiber, S.; Horstmann, S.; Pütz, B. et al.; Reppermund, S.; Heck, A.; Pfister, H.; Holsboer, F.; Müller-Myhsok, B.: Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)